• 1
    Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology. Br Med J (Clin Res Ed) 1982; 285: 606.
  • 2
    Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 4259.
  • 3
    Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 25: 16517.
  • 4
    Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS 1989; 97 Suppl 6: 123.
  • 5
    Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegener's autoantigen decoded [letter]. Nature 1990; 346: 520.
  • 6
    Ludemann J, Utecht B, Gross WL. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 1990; 171: 35762.
  • 7
    Gupta SK, Niles JL, McCluskey RT, Arnaout MA. Identity of Wegener's autoantigen (p29) with proteinase 3 and myeloblastin [letter]. Blood 1990; 76: 2162.
  • 8
    Hoffman GS, Specks U. Anti-neutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 152137.
  • 9
    Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999; 111: 50713.
  • 10
    Russell KA, Specks U. Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon. Rheum Dis Clin North Am 2001; 27: 81532.
  • 11
    Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 95563.
  • 12
    Jenne DE. Structure of the azurocidin, proteinase 3, and neutrophil elastase genes: implications for inflammation and vasculitis. Am J Respir Crit Care Med 1994; 150: S14754.
  • 13
    Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 1990; 81: 3803.
  • 14
    Gallicchio MC, Savige JA. Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections. Clin Exp Immunol 1991; 84: 2327.
  • 15
    Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, The H, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993; 52: 11520.
  • 16
    Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM 1995; 88: 77583.
  • 17
    Apenberg S, Andrassy K, Worner I, Hansch GM, Roland J, Morcos M, et al. Antibodies to neutrophil elastase: a study in patients with vasculitis. Am J Kidney Dis 1996; 28: 17885.
  • 18
    Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody–positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000; 43: 40513.
  • 19
    Trimarchi M, Gregorini G, Facchetti F, Morassi ML, Manfredini C, Maroldi R, et al. Cocaine-induced midline destructive lesions: clinical, radiographic, histopathologic, and serologic features and their differentiation from Wegener granulomatosis. Medicine (Baltimore) 2001; 80: 391404.
  • 20
    Russell KA, Wiegert E, Schroeder DR, Homburger HA, Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol 2002; 103: 196203.
  • 21
    Specks U, Fass DN, Fautsch MP, Hummel AM, Viss MA. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA. FEBS Lett 1996; 390: 26570.
  • 22
    Specks U, Wiegert EM, Homburger HA. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 1997; 109: 28695.
  • 23
    Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 1989; 64: 2836.
  • 24
    Sun J, Fass DN, Viss MA, Hummel AM, Tang H, Homburger HA, et al. A proportion of proteinase 3-specific anti-neutrophil cytoplasmic antibodies only react with proteinase 3 after cleavage of its N-terminal activation dipeptide. Clin Exp Immunol 1998; 114: 3206.
  • 25
    Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, et al. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods 1998; 211: 11123.
  • 26
    National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices: approved guideline. NCCLS publication EP5-A. Villanova (PA): NCCLS; 1999.
  • 27
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 11017.
  • 28
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 18792.
  • 29
    Hajian-Tilaki KO, Hanley JA. Comparison of three methods for estimating the standard error of the area under the curve in ROC analysis of quantitative data. Acad Radiol 2002; 9: 127885.
  • 30
    Jenne DE, Frohlich L, Hummel AM, Specks U. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis. FEBS Lett 1997; 408: 18790.
  • 31
    Baugh RJ, Travis J. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 1976; 15: 83641.
  • 32
    Gullberg U, Lindmark A, Lindgren G, Persson A-M, Nilsson E, Olsson I. Carboxy-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J Biol Chem 1995; 270: 129128.
  • 33
    Garwicz D, Lindmark A, Hellmark T, Gladh M, Jogl J, Gullberg U. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J Leukoc Biol 1997; 61: 11323.
  • 34
    Langford CA. The diagnostic utility of c-ANCA in Wegener's granulomatosis. Cleve Clin J Med 1998; 65: 13540.
  • 35
    Nassberger L, Jonsson H, Sjoholm AG, Sturfelt G. Circulating anti-elastase in systemic lupus erythematosus [letter]. Lancet 1989; 1: 509.
  • 36
    Dalpe G, Beliveau A, Menard HA, Boire G. Cross-reactivity of an anti-proteinase 3 antibody to elastase. Autoimmunity 1994; 17: 2535.
  • 37
    Stone JH, Talor M, Stebbing J, Uhlfelder ML, Rose NR, Carson KA, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 2000; 13: 42434.